Soussain, C <br/><br/>
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Feb 2001 
 - 742-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2001.19.3.742  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Busulfan--administration & dosage<br/>Central Nervous System Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Etoposide--administration & dosage<br/>Eye Neoplasms--drug therapy<br/>Feasibility Studies<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Lymphoma, Large-Cell, Immunoblastic--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Lymphoma, T-Cell--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Nervous System Diseases--chemically induced<br/>Salvage Therapy<br/>Thiotepa--administration & dosage